아시아태평양의 인터벤션 이미징 시장 : 분석 및 예측(2023-2033년)

“The Asia-Pacific Interventional Imaging Market Expected to Reach $2.44 Billion by 2033.”

Introduction to Asia-Pacific (APAC) Interventional Imaging Market

The Asia-Pacific interventional imaging market was valued at $1.11 billion in 2023 and is expected to reach $2.44 billion by the end of 2033, growing at a CAGR of 8.18% during the forecast period 2023-2033. This expansion can be ascribed to rising demand for minimally invasive procedures, as well as increased use of new technology and the prevalence of chronic conditions. The market encompasses a variety of techniques, consumables, systems, and software designed for chronic disease diagnosis and treatment.

Market Introduction

The Asia-Pacific interventional imaging market is critical to the evolution of imaging systems, especially in medical diagnostics and therapy. It allows for accurate diagnosis and early disease identification. This early discovery improves treatment outcomes and the prognosis of patients. Interventional imaging technology has transformed therapy and detection, resulting in breakthroughs and promised future developments.

Market Segmentation:

Segmentation 1: by Offering

• Interventional Imaging Systems
• Interventional Imaging Software
• Consumables

Segmentation 2: by Application

• Cardiology
• Neurology
• Musculoskeletal
• Oncology
• Urology
• Gastroenterology
• Obstetrics
• Gynaecology
• Others

Segmentation 3: by End User

• Hospitals
• Ambulatory Surgical Centres
• Clinics

Segmentation 4: by Country

• Japan
• China
• India
• Australia
• South Korea
• Singapore
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific interventional imaging market (by offering) has been segmented into detailed segments, including different types of interventional imaging systems, namely X-ray, CT scanners, MRI systems, and ultrasound imaging systems. Moreover, the study provides the reader with a detailed understanding of the different applications of these products.

Competitive Strategy: Key players in the Asia-Pacific interventional imaging market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Asia-Pacific interventional imaging market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

Table of Contents

Executive Summary

Research Methodology

1. Markets

• 1.1. Product Definition
• 1.2. Inclusion and Exclusion
• 1.3. Key Findings

2. Interventional Imaging Market: Overview

• 2.1. Market Introduction
• 2.2. Market Footprint and Growth Potential, $Billion, 2022-2033
• 2.3. Current and Future State of Interventional Imaging in Industry

3. Industry Outlook

• 3.1. Key Trends
• 3.2. Patent Analysis
  • 3.2.1. Patent Analysis (by Year)
  • 3.2.2. Patent Analysis (by Country)
• 3.3. COVID-19 Impact on Interventional Imaging Market
  • 3.3.1. COVID-19 Impact: Current Scenario of the Market
  • 3.3.2. Pre- and During-COVID-19 Impact Assessment
    • 3.3.2.1. Pre-COVID-19
    • 3.3.2.2. During-COVID-19
• 3.4. Regulatory Requirements
  • 3.4.1. Regulatory and Legal Requirements and Framework in the U.S.
  • 3.4.2. Regulatory and Legal Requirements and Framework in Europe
  • 3.4.3. Regulatory and Legal Requirements and Framework in Asia-Pacific
    • 3.4.3.1. China
    • 3.4.3.2. Japan
    • 3.4.3.3. India
    • 3.4.3.4. Australia
• 3.5. Product Benchmarking

4. Interventional Imaging Market Dynamics

• 4.1. Impact Analysis
• 4.2. Market Drivers
  • 4.2.1. Increasing Demand for Minimally Invasive Surgical Procedures
  • 4.2.2. Technological Advancements in Surgical Procedures and Imaging Technologies
    • 4.2.2.1. Rising Adoption of 4K Imaging Technologies
    • 4.2.2.2. 3D and 4D Imaging
  • 4.2.3. Upsurge in Incidence of Chronic Diseases Leading to Growth in the Adoption of Interventional Imaging
    • 4.2.3.1. Cardiovascular Diseases
    • 4.2.3.2. Cancer
  • 4.2.4. Increasing Adoption of Inorganic Growth Strategies in the Market
• 4.3. Market Restraints
  • 4.3.1. Shortages of Skilled Professionals
  • 4.3.2. Restrictive Reimbursement Landscape
  • 4.3.3. High Cost of Interventional Imaging Systems
• 4.4. Market Opportunities
  • 4.4.1. Integration of AI in Interventional Imaging
  • 4.4.2. Collaboration with Hospitals, Clinics, and Other Healthcare Facilities for Development of Interventional Imaging Solutions

5. Interventional Imaging Market (by Region), ($Billion), 2022-2033

• 5.1. Overview
• 5.1. Asia-Pacific
  • 5.1.1. Market Sizing and Forecast
    • 5.1.1.1. Asia-Pacific Interventional Imaging Market (by Offering)
    • 5.1.1.2. Asia-Pacific Interventional Imaging Market (by Application)
    • 5.1.1.3. Asia-Pacific Interventional Imaging Market (by End User)
  • 5.1.2. Japan
    • 5.1.2.1. Market Sizing and Forecast
      • 5.1.2.1.1. Japan Interventional Imaging Market (by Offering)
      • 5.1.2.1.2. Japan Interventional Imaging Market (by Application)
      • 5.1.2.1.3. Japan Interventional Imaging Market (by End User)
  • 5.1.3. China
    • 5.1.3.1. Market Sizing and Forecast
      • 5.1.3.1.1. China Interventional Imaging Market (by Offering)
      • 5.1.3.1.2. China Interventional Imaging Market (by Application)
      • 5.1.3.1.3. China Interventional Imaging Market (by End User)
  • 5.1.4. Australia
    • 5.1.4.1. Market Sizing and Forecast
      • 5.1.4.1.1. Australia Interventional Imaging Market (by Offering)
      • 5.1.4.1.2. Australia Interventional Imaging Market (by Application)
      • 5.1.4.1.3. Australia Interventional Imaging Market (by End User)
  • 5.1.5. South Korea
    • 5.1.5.1. Market Sizing and Forecast
      • 5.1.5.1.1. South Korea Interventional Imaging Market (by Offering)
      • 5.1.5.1.2. South Korea Interventional Imaging Market (by Application)
      • 5.1.5.1.3. South Korea Interventional Imaging Market (by End User)
  • 5.1.6. India
    • 5.1.6.1. Market Sizing and Forecast
      • 5.1.6.1.1. India Interventional Imaging Market (by Offering)
      • 5.1.6.1.2. India Interventional Imaging Market (by Application)
      • 5.1.6.1.3. India Interventional Imaging Market (by End User)
  • 5.1.7. Singapore
    • 5.1.7.1. Market Sizing and Forecast
      • 5.1.7.1.1. Singapore Interventional Imaging Market (by Offering)
      • 5.1.7.1.2. Singapore Interventional Imaging Market (by Application)
      • 5.1.7.1.3. Singapore Interventional Imaging Market (by End User)
  • 5.1.8. Rest-of-Asia-Pacific
    • 5.1.8.1. Market Sizing and Forecast
      • 5.1.8.1.1. Rest-of-Asia-Pacific Interventional Imaging Market (by Offering)
      • 5.1.8.1.2. Rest-of-Asia-Pacific Interventional Imaging Market (by Application)
      • 5.1.8.1.3. Rest-of-Asia-Pacific Interventional Imaging Market (by End User)

6. Company Profiles

• 6.1. Interventional Imaging Ecosystem Active Players
  • 6.1.1. Canon Inc.
    • 6.1.1.1. Role of Canon Inc. in the Interventional Imaging Market
    • 6.1.1.2. Recent Developments
    • 6.1.1.3. Analyst Perspective
  • 6.1.2. FUJIFILM Holdings Corporation
    • 6.1.2.1. Role of FUJIFILM Holdings Corporation in the Interventional Imaging Market
    • 6.1.2.2. Analyst Perspective
  • 6.1.3. Shimadzu Corporation
    • 6.1.3.1. Role of Shimadzu Corporation in the Interventional Imaging Market
    • 6.1.3.2. Analyst Perspective
  • 6.1.4. Terumo Corporation
    • 6.1.4.1. Role of Terumo Corporation in the Interventional Imaging Market
    • 6.1.4.2. Analyst Perspective
    • 6.1.4.3. Analyst Perspective
  • 6.1.5. Trivitron Healthcare
    • 6.1.5.1. Role of Trivitron Healthcare in the Interventional Imaging Market
    • 6.1.5.2. Recent Developments
    • 6.1.5.3. Analyst Perspective